Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
MA Dawson, EJ Gudgin, SJ Horton, G Giotopoulos, E Meduri, S Robson, E Cannizzaro, H Osaki, M Wiese, S Putwain, CY Fong, C Grove, J Craig, A Dittmann, D Lugo, P Jeffrey, G Drewes, K Lee, L Bullinger, RK Prinjha Show all
Leukemia | NATURE PUBLISHING GROUP | Published : 2014
Awarded by Cancer Research UK
Awarded by Worldwide Cancer Research
Work in the Huntly laboratory is funded by Leukaemia Lymphoma Research, the Kay Kendall Leukaemia fund, the Wellcome Trust, Cancer Research UK and the Cambridge NIHR Biomedical Research Centre. Work in the Kouzarides laboratory is funded by a program grant from Cancer Research UK. MAD is a Wellcome Trust-Beit Intermediate Fellow. CYF is funded by a PhD fellowship from the Leukaemia Foundation Australia and GSV is a Wellcome Trust Senior Fellow.